|Age:||18 years or older|
|Keywords:||AMG-232, Decitabine, cancer, leukemia|
|Type:||Drug study, Phase 1|
You are being asked to take part in this study because you have Acute Myeloid Leukemia. You have may have been treated with chemotherapy, and your disease is now growing, or you may have been newly diagnosed with the disease.
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.